Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-02-24 @ 2:31 PM
Study NCT ID:
NCT02197169
Status:
COMPLETED
Last Update Posted:
2018-07-16
First Post:
2014-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Sponsor:
DNAtrix, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Glioblastoma or Gliosarcoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Brain | View |
| None | Brain Cancer | View |
| None | Brain Neoplasms | View |
| None | Central Nervous System Diseases | View |
| None | Central Nervous System Neoplasms | View |
| None | CNS | View |
| None | Conditionally Replication-Competent Adenovirus | View |
| None | DNX-2401 | View |
| None | Delta-24-RGD | View |
| None | Glioma | View |
| None | Glioblastoma | View |
| None | Gliosarcoma | View |
| None | Interferon gamma | View |
| None | Malignant brain tumor | View |
| None | Neoplasms, Neuroepithelial | View |
| None | Neuroectodermal Tumors | View |
| None | Neoplasms, Germ Cell and Embryonal | View |
| None | Neoplasms by Histologic Type | View |
| None | Neoplasms, Glandular and Epithelial | View |
| None | Neoplasms, Nerve Tissue | View |
| None | Nervous System Diseases | View |
| None | Alcyone Lifesciences | View |
| None | AMC™ | View |
| None | Cannula | View |
| None | Alcyone MEMS Cannula (AMC™) System | View |